Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong(University of Connecticut), Valina L. Dawson(Johns Hopkins University), Stewart Neifert(Johns Hopkins University), Ted M. Dawson(Johns Hopkins University), Sung-Ung Kang(Johns Hopkins University), Han Seok Ko(Johns Hopkins University), Lorraine Iacovitti(Thomas Jefferson University), Xiaobo Mao(Johns Hopkins University), Jeannette N. Stankowski(AstraZeneca (Brazil)), Haisong Jiang(Kyushu University), Senthilkumar S. Karuppagounder(Johns Hopkins University), Qinfang Liu(University of Connecticut), Byoung Dae Lee(Kyung Hee University), Yunjong Lee(Sungkyunkwan University), Deborah A. Swing(National Cancer Institute), Jonathan C. Grima(Johns Hopkins Medicine), Lino Tessarollo(National Institutes of Health)
Cited by 98
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
|Molecular Neurodegeneration|2020|484